Brief: Summit Says It Raised $200 Million And Expands License Territories For Ivonescimab

Summit Therapeutics

03/06/2024 10:32

June 3 (Reuters) - Summit Therapeutics Inc  SMMT.O :
    * SUMMIT RAISES $200 MILLION; ALSO EXPANDS LICENSE
TERRITORIES FOR
IVONESCIMAB
    * SUMMIT THERAPEUTICS - EXPANDED LICENSE TERRITORIES FOR
IVONESCIMAB IN DEAL WITH AKESO TO INCLUDE LATIN AMERICA,
MIDEAST, AND AFRICA
    * SUMMIT THERAPEUTICS - RECEIVED & ACCEPTED UNSOLICITED
OFFER FROM
INSTITUTIONAL INVESTOR TO PURCHASE 22.2 MILLION SHARES OF CO'S
COMMON STOCK AT $9.00 PER SHARE

Source text for Eikon:  ID:nBw3SlhQka 
Further company coverage:  SMMT.O 

 ((Reuters.Briefs@thomsonreuters.com;))